Natural History Study of Cutaneous Neurofibromas in People with NF1
John Hopkins Medicine Center is currently conducting a study on those with neurofibromatosis type one (NF1) and cutaneous neurofibromas also…
Read More
Check out past blogs and news!
John Hopkins Medicine Center is currently conducting a study on those with neurofibromatosis type one (NF1) and cutaneous neurofibromas also…
Read More
If you’re a post high school student with neurofibromatosis or schwannomatosis, and you live in NF Midwest’s service region of Illinois,…
Read More
Insurance issues are a huge headache no one wants. Many are in the habit of tossing out their insurance benefit…
Read More
Optic Pathway Gliomas are often referred to as OPG and may affect those with neurofibromatosis type1 (NF1). In most cases…
Read More
$25 million has been allocated specifically for the Neurofibromatosis Research Program (NFRP) in the Fiscal Year 2023 Omnibus appropriates bill…
Read More
We’re putting 2020 through 2022 in the review mirror and looking forward to an amazing 2023. Honestly, it’s been a…
Read MoreWalk4NF Columbia Details Get ready for the annual Columbia Walk4NF! Plus, NF Midwest is celebrating over 40 years as a…
Read MoreNeurofibromatosis Midwest is very excited to have Sarah Selogic join our team as our Care and Outreach Coordinator. Sarah is…
Read MoreWalk4NF Madison Details Get ready for the annual Madison Walk4NF! Plus, NF Midwest is celebrating over 40 years as a…
Read MoreClassrooms that Care is a service-learning program that teaches students and/or educational staff about neurofibromatosis (NF) and allied disorders through…
Read More
© 2026 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.
.png)
